MedTrace Logo

Conventional With Stereotactic Radiotherapy for Pain Reduction and Quality of Life in Spinal Metastases

NCT02407795 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2022-05-13

No results posted yet for this study

Summary

A randomized, multicentre, phase III study comparing conventional radiotherapy (1x8Gy) with stereotactic radiotherapy (1x20Gy) for pain reduction and quality of life in spinal metastases.

Conditions

  • Spinal Metastases

Interventions

RADIATION

conventional radiotherapy

1x8Gy

RADIATION

stereotactic radiotherapy

1x20Gy or equivalent dose fractionation schedule

Sponsors & Collaborators

  • Koningin Wilhelmina Fonds

    collaborator OTHER

  • Maastro Clinic, The Netherlands

    collaborator OTHER

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • P Braam, MD · Radboudumc Nijmegen

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2018-08-01
Completion
2021-11-10

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02407795 on ClinicalTrials.gov